These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36150804)

  • 1. Drugs Used in Circadian Sleep-Wake Rhythm Disturbances.
    Burgess HJ; Emens JS
    Sleep Med Clin; 2022 Sep; 17(3):421-431. PubMed ID: 36150804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs Used in Circadian Sleep-Wake Rhythm Disturbances.
    Burgess HJ; Emens JS
    Sleep Med Clin; 2018 Jun; 13(2):231-241. PubMed ID: 29759273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs Used in Circadian Sleep-Wake Rhythm Disturbances.
    Burgess HJ; Emens JS
    Sleep Med Clin; 2020 Jun; 15(2):301-310. PubMed ID: 32386703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Melatonin as a regulator of human sleep and circadian systems].
    Mishima K
    Nihon Rinsho; 2012 Jul; 70(7):1139-44. PubMed ID: 22844795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Light and Melatonin and Other Melatonin Receptor Agonists on Human Circadian Physiology.
    Emens JS; Burgess HJ
    Sleep Med Clin; 2015 Dec; 10(4):435-53. PubMed ID: 26568121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R
    Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigational melatonin receptor agonists.
    Hardeland R
    Expert Opin Investig Drugs; 2010 Jun; 19(6):747-64. PubMed ID: 20408738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the pharmacological management of non-24-h sleep-wake disorder.
    Nishimon S; Nishino N; Nishino S
    Expert Opin Pharmacother; 2021 Jun; 22(8):1039-1049. PubMed ID: 33618599
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of a patient with a circadian sleep-wake disorder using a combination of melatonin and metoprolol.
    Gehrman PR; Anafi RC
    J Clin Sleep Med; 2021 Oct; 17(10):2121-2124. PubMed ID: 34032203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.
    Williams WP; McLin DE; Dressman MA; Neubauer DN
    Pharmacotherapy; 2016 Sep; 36(9):1028-41. PubMed ID: 27500861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patients.
    Stahl SM
    CNS Spectr; 2014 Dec; 19(6):475-8. PubMed ID: 25422900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic circadian period of sighted patients with circadian rhythm sleep disorder, free-running type.
    Kitamura S; Hida A; Enomoto M; Watanabe M; Katayose Y; Nozaki K; Aritake S; Higuchi S; Moriguchi Y; Kamei Y; Mishima K
    Biol Psychiatry; 2013 Jan; 73(1):63-9. PubMed ID: 22846439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review.
    de Jonghe A; Korevaar JC; van Munster BC; de Rooij SE
    Int J Geriatr Psychiatry; 2010 Dec; 25(12):1201-8. PubMed ID: 21086534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bright light, dark and melatonin can promote circadian adaptation in night shift workers.
    Burgess HJ; Sharkey KM; Eastman CI
    Sleep Med Rev; 2002 Oct; 6(5):407-20. PubMed ID: 12531129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent.
    Wyatt JK; Dijk DJ; Ritz-de Cecco A; Ronda JM; Czeisler CA
    Sleep; 2006 May; 29(5):609-18. PubMed ID: 16774150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Melatonin receptor agonist].
    Uchiyama M
    Nihon Rinsho; 2015 Jun; 73(6):1017-22. PubMed ID: 26065135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tasimelteon for treating non-24-h sleep-wake rhythm disorder.
    Nishimon S; Nishimon M; Nishino S
    Expert Opin Pharmacother; 2019 Jun; 20(9):1065-1073. PubMed ID: 30990759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin: pharmacological aspects and clinical trends.
    Rios ER; Venâncio ET; Rocha NF; Woods DJ; Vasconcelos S; Macedo D; Sousa FC; Fonteles MM
    Int J Neurosci; 2010 Sep; 120(9):583-90. PubMed ID: 20707632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in non-24-h sleep-wake rhythm disorder in a sighted individual treated with a melatonin receptor agonist.
    Connolly PJ; Quigg M; Davis EM
    Sleep Med; 2024 Apr; 116():41-42. PubMed ID: 38422783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.